Tundra Space

Tundra Space

Book DemoDirectoryLog InSign Up

Clinical Research Directory

Browse clinical research sites, groups, and studies.

SitesGroupsStudies
Back to Studies
RECRUITING
NCT07693452
PHASE2

Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms

Sponsor: University of California, Irvine

View on ClinicalTrials.gov

Summary

This is a pilot, open-label clinical trial determining the feasibility of metformin therapy in subjects with pseudomyxoma peritoneal (PMP) secondary to appendiceal mucinous neoplasms (AMNs).

Official title: Use of Metformin in Patients With Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2026-06-18

Completion Date

2029-07

Last Updated

2026-07-09

Healthy Volunteers

No

Conditions

Appendiceal Mucinous NeoplasmPseudomyxoma Peritonei

Interventions

DRUG

Metformin

Given PO

Locations (1)

Chao Family Comprehensive Cancer Center, University of California, Irvine

Orange, California, United States